Cargando…

Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis

Non-alcoholic steatohepatitis (NASH) is gradually becoming one of the most common and health-endangering diseases; therefore, it is very important to prevent the occurrence of NASH and prevent simple non-alcoholic fatty liver (NAFL) from further developing into NASH. We fed mice a high-fat diet (HFD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chao, Wan, Min, Xu, Dengfeng, Pan, Da, Xia, Hui, Yang, Ligang, Sun, Guiju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509295/ https://www.ncbi.nlm.nih.gov/pubmed/34639207 http://dx.doi.org/10.3390/ijms221910858

Ejemplares similares

Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism
por: Lei, Yuanyuan, et al.
Publicado: (2022)

Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice
por: Kasai, Kaichi, et al.
Publicado: (2023)

Lentinan Supplementation Protects the Gut–Liver Axis and Prevents Steatohepatitis: The Role of Gut Microbiota Involved
por: Yang, Xiaoying, et al.
Publicado: (2022)

Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice
por: Yamada, Shoji, et al.
Publicado: (2018)

Beneficial Effects of Dietary Flaxseed Oil through Inflammation Pathways and Gut Microbiota in Streptozotocin-Induced Diabetic Mice
por: Xia, Hui, et al.
Publicado: (2023)

Lactiplantibacillus plantarum LPJZ-658 Improves Non-Alcoholic Steatohepatitis by Modulating Bile Acid Metabolism and Gut Microbiota in Mice
por: Liu, Liming, et al.
Publicado: (2023)

Val‐Val‐Tyr‐Pro protects against non‐alcoholic steatohepatitis in mice by modulating the gut microbiota and gut‐liver axis activation
por: Xie, Xinshu, et al.
Publicado: (2021)

Dietary Modulation of the Human Gut Microbiota and Metabolome with Flaxseed Preparations
por: Kleigrewe, Karin, et al.
Publicado: (2022)

The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
por: Ni, Yiming, et al.
Publicado: (2022)

Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis
por: Liakina, Valentina, et al.
Publicado: (2022)

Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials
por: Yang, Chao, et al.
Publicado: (2021)

Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice
por: Zhang, Xiaoxia, et al.
Publicado: (2017)

Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver–Gut Axis
por: Grüner, Niklas, et al.
Publicado: (2021)

A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility
por: Wei, Meilin, et al.
Publicado: (2020)

The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais
por: Sobhonslidsuk, Abhasnee, et al.
Publicado: (2018)

Rifaximin Ameliorates Non-alcoholic Steatohepatitis in Mice Through Regulating gut Microbiome-Related Bile Acids
por: Jian, Jie, et al.
Publicado: (2022)

Dietary Flaxseed and Flaxseed Oil Differentially Modulate Aspects of the Microbiota Gut–Brain Axis Following an Acute Lipopolysaccharide Challenge in Male C57Bl/6 Mice
por: Livingston, Dawson B. H., et al.
Publicado: (2023)

Suppression of the gut microbiota–bile acid–FGF19 axis in patients with atrial fibrillation
por: Zuo, Kun, et al.
Publicado: (2023)

Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside
por: Yang, Min, et al.
Publicado: (2021)

Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease
por: Mulak, Agata
Publicado: (2021)

Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease
por: Li, Lingfeng, et al.
Publicado: (2022)

Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo
por: Li, Hongshan, et al.
Publicado: (2023)

Pro‐inflammatory signalling and gut‐liver axis in non‐alcoholic and alcoholic steatohepatitis: Differences and similarities along the path
por: Glaser, Trenton, et al.
Publicado: (2020)

Bile Acid and Gut Microbiota in Irritable Bowel Syndrome
por: Min, Yang Won, et al.
Publicado: (2022)

Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
por: Mouries, Juliette, et al.
Publicado: (2019)

Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites
por: Zhu, Mingzhe, et al.
Publicado: (2023)

Bile Acid Supplementation Improves Murine Pancreatitis in Association With the Gut Microbiota
por: Wan, You-Dong, et al.
Publicado: (2020)

Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity
por: Su, Xiaomin, et al.
Publicado: (2023)

The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
por: Zhang, Yu-Lin, et al.
Publicado: (2022)

Metabolism of Cholesterol and Bile Acids by the Gut Microbiota
por: Gérard, Philippe
Publicado: (2013)

Bile acids, gut microbiota and metabolic surgery
por: Tu, Jui, et al.
Publicado: (2022)

Gegen Qinlian Decoction Attenuates High-Fat Diet-Induced Steatohepatitis in Rats via Gut Microbiota
por: Guo, Yi, et al.
Publicado: (2018)

Short‐term exposure to synthetic flaxseed lignan LGM2605 alters gut microbiota in mice
por: Badger, Reagan, et al.
Publicado: (2021)

The Crosstalk between Gut Microbiota and Bile Acids Promotes the Development of Non-Alcoholic Fatty Liver Disease
por: Li, Zhonglin, et al.
Publicado: (2023)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021)

Gut Microbiota-brain Axis
por: Wang, Hong-Xing, et al.
Publicado: (2016)

The microbiota-gut- hippocampus axis
por: Salami, Mahmoud, et al.
Publicado: (2022)

Bear bile powder ameliorates type 2 diabetes via modulation of metabolic profiles, gut microbiota, and metabolites
por: Chen, Xing-Ling, et al.
Publicado: (2023)

Rethinking the bile acid/gut microbiome axis in cancer
por: Phelan, John P., et al.
Publicado: (2017)

Yinzhihuang oral liquid protects against non-alcoholic steatohepatitis via modulation of the gut-liver axis in mice
por: Li, Shuyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9htktsr1h7j30itbcohe2noe6j